Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Beretta

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|December 16, 2006
Mechanisms of cellular resistance to camptothecinsG L Beretta, P Perego, F Zunino
Biochemistry and Molecular Biology International|August 1, 1994
Chemical modification of lysyl residues of Rhodotorula gracilis D-amino acid oxidaseG Gadda, G L Beretta, M S Pilone
FEBS Letters|April 24, 1995
Reactivity of histidyl residues in D-amino acid oxidase from Rhodotorula gracilisG Gadda, G L Beretta, M S Pilone
Current Medicinal Chemistry|December 30, 2011
Targeting DNA topoisomerase I with non-camptothecin poisonsG L Beretta, V Zuco, P Perego, et al.
Current Medicinal Chemistry|February 26, 2013
Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drugG L Beretta, L Gatti, P Perego, et al.
Mini Reviews in Medicinal Chemistry|August 20, 2009
ABC transporters as potential targets for modulation of drug resistanceL Gatti, G L Beretta, G Cossa, et al.
Mini Reviews in Medicinal Chemistry|August 12, 2008
Small molecules targeting p53 to improve antitumor therapyG L Beretta, L Gatti, V Benedetti, et al.
Cancer Research|August 14, 1999
Tethering a type IB topoisomerase to a DNA site by enzyme fusion to a heterologous site-selective DNA-binding protein domainG L Beretta, M Binaschi, E Zagni, et al.
Current Medicinal Chemistry|August 16, 2011
Novel insights into targeting ATP-binding cassette transporters for antitumor therapyL Gatti, G Cossa, G L Beretta, et al.
Current Medicinal Chemistry|February 20, 2010
Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatmentG L Beretta, G Cossa, L Gatti, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|December 16, 2006
Mechanisms of cellular resistance to camptothecinsG L Beretta, P Perego, F Zunino
Biochemistry and Molecular Biology International|August 1, 1994
Chemical modification of lysyl residues of Rhodotorula gracilis D-amino acid oxidaseG Gadda, G L Beretta, M S Pilone
FEBS Letters|April 24, 1995
Reactivity of histidyl residues in D-amino acid oxidase from Rhodotorula gracilisG Gadda, G L Beretta, M S Pilone
Current Medicinal Chemistry|December 30, 2011
Targeting DNA topoisomerase I with non-camptothecin poisonsG L Beretta, V Zuco, P Perego, et al.
Current Medicinal Chemistry|February 26, 2013
Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drugG L Beretta, L Gatti, P Perego, et al.
Mini Reviews in Medicinal Chemistry|August 20, 2009
ABC transporters as potential targets for modulation of drug resistanceL Gatti, G L Beretta, G Cossa, et al.
Mini Reviews in Medicinal Chemistry|August 12, 2008
Small molecules targeting p53 to improve antitumor therapyG L Beretta, L Gatti, V Benedetti, et al.
Cancer Research|August 14, 1999
Tethering a type IB topoisomerase to a DNA site by enzyme fusion to a heterologous site-selective DNA-binding protein domainG L Beretta, M Binaschi, E Zagni, et al.
Current Medicinal Chemistry|August 16, 2011
Novel insights into targeting ATP-binding cassette transporters for antitumor therapyL Gatti, G Cossa, G L Beretta, et al.
Current Medicinal Chemistry|February 20, 2010
Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatmentG L Beretta, G Cossa, L Gatti, et al.
Pageof 2